Ogilvie, Kelvin K.

Kelvin K. Ogilvie (Nova Scotia) is past president of Acadia University in Wolfville.  An award-winning international expert in biotechnology, bioorganic chemistry and genetic engineering, Dr. Ogilvie’s scientific accomplishments include the development of the “Gene Machine,” an automated process for the manufacture of DNA, and the invention of the drug Ganciclovir, which is used worldwide to fight infections that occur when one’s immune system is weakened.  During his ten years of service as President and Vice Chancellor at Acadia, Dr. Ogilvie proved to be an equally innovative administrator, introducing the groundbreaking “Acadia Advantage” program that has been internationally recognized.  Dr. Ogilvie has served on numerous national and international organizations including the National Biotechnology Advisory Committee and the National Advisory Board for Science and Technology.  He recently completed a three-year term as chair of the Nova Scotia Premier’s Council for Innovation and currently serves as Senior Fellow for Postsecondary Education at the Atlantic Institute for Market Studies.  Dr. Ogilvie is a member of the Board of Genome Canada and chairs both the Advisory Board of National Research Council’s Institute of Marine Bioscience and the Advisory Board of the Atlantic Innovation Fund.  For his numerous contributions to science, technology and higher education in Canada, Dr. Ogilvie was named to the Order of Canada in 1991.  Dr. Ogilvie is married and has two children and three grandchildren.